Actinium Pharmaceuticals, Inc. (ATNM) Earnings
|
Expand Research on ATNM
| Next EPS Date | N/A | EPS Growth Rate | N/A |
|---|---|---|---|
| Average EPS % Beat Rate | -104.0% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | +0.3% | Normal Earnings Time | Before Open |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
3/13/26  |
Q425 | N/A | -$0.18 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 11/24/25 |
Q325 | N/A | -$0.32 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 8/25/25 |
Q225 | N/A | -$0.35 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 8/18/25 |
Q225 | N/A | -$0.35 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 8/6/25 |
Q225 | N/A | -$0.35 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 8/5/25 |
Q225 | N/A | -$0.35 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 8/4/25 |
Q225 | N/A | -$0.35 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 8/1/25 |
Q225 | N/A | -$0.35 | N/A | N/A | N/A | N/A | N/A | N/A |
